로딩 중…
지수 로딩 중…
Aldeyra Therapeutics, Inc.
ALDX· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$1.96+7.10%
2026-06-18
Price Chart
Aldeyra Therapeutics, Inc.-38.17%
Financials
No data
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $118M |
| Revenue | $0.00 |
| Net Income | $-27M |
| Total Assets | $66M |
| Net Assets | $42M |
| Value | |
| P/B | 2.80x |
| FCF Yield | -21.98% |
| Profitability | |
| ROE | -64.92% |
| ROA | -41.17% |
| Financial Health | |
| Debt Ratio | 57.70% |
| Total Debt | $16M |
| FCF | $-26M |
| Cash | $65M |
| Current Ratio | 2.72x |
| Performance | |
| 1Y Return | -38.17% |
| 1M Return | 27.27% |
| From 52W High | -68.28% |
| 1Y MDD | -81.44% |
| Trading | |
| Volume | 2,154,551 shares |
| Trading Value | $4M |
| Per Share | |
| EPS | $-0.56 |
| BPS | $735511.14 |